Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Jun 14, 2021
Date Accepted: Dec 2, 2021
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Ethical Issues Surrounding Social Media Recruitment in Clinical Studies: A Mapping Review
ABSTRACT
Background:
Social media recruitment for clinical studies holds the promise of being a cost-effective way to attract traditionally marginalized populations and promote patient engagement with researchers and a particular study.
Objective:
Here, we present a comprehensive overview of the ethical benefits and risks to be considered for social media recruitment in clinical studies and develop practical recommendations on how to implement these considerations.
Methods:
We first reviewed the conceptual and empirical literature for ethical benefits and challenges related to social media recruitment.
Results:
From these, we derived three criteria to be evaluated and assessed a priori to decide the eligibility of social media recruitment for clinical studies: information and consent, risks for target groups, and recruitment effectiveness. We then discuss the practical implications of these criteria for researchers.
Conclusions:
Social media based recrutiment is a highly context-sensitive form of clinical study recruitment. Its eligibility vastly depends upon information and consent, risks for target groups, and the potential recruitment effectiveness.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.